Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06023615 · ClinicalTrials.gov registry record · NA
MITIGAAT: Multifaceted Intervention to Improve Graft Outcome Disparities in African American Kidney Transplants
A NA study of Medication Adherence and Medication Compliance, sponsored by Medical University of South Carolina.
- Recruiting
- Registry status
- NA
- Development phase
- 190
- Enrollment target
- 1
- Study location
NCT06023615: Recruiting NA study of Medication Adherence and Medication Compliance, sponsored by Medical University of South Carolina.
NCT06023615 is a NA study of Medication Adherence and Medication Compliance that is actively recruiting participants, run by Medical University of South Carolina. The registered enrollment target is 190 participants, below the 1,653-participant average among 52 other Medication Adherence trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06023615, a NA study of Medication Adherence and Medication Compliance, is actively recruiting participants, sponsored by Medical University of South Carolina.
- RECRUITING
- Registry status
- NA
- Development phase
- 190 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a randomized study to test a smartphone app that a pharmacist will use to help kidney transplant patients track their medications, blood pressures, and blood sugars in those with diabetes. The goal of this study is to improve care and outcomes in kidney transplant patients and, in particular, help African American patients have better outcomes after transplant.
Primary Outcome
Medication adherence will be measured by using tacrolimus trough concentration variability, which is a validated proxy measure of medication adherence. This is defined as the intrapatient tacrolimus concentration coefficient of variation (CV): standard deviation divided by the mean for each patient. All outpatient true trough tacrolimus levels drawn will be used to calculate the tacrolimus CV. This will be assessed every 3 months, which aligns with the minimum lab draw schedule for kidney transp
Conditions Studied
Interventions
- OTHER mHealth app/dashboard
Study Locations (1)
South Carolina
- Medical University of South Carolina - Charleston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 190 participants |
| Start Date | 2024-02-27 |
| Est. Completion | 2027-10-31 |
| Phase | NA |
What NCT06023615 shows while recruiting
NCT06023615 is an interventional study that assigns participants to a tested intervention. The registered 190 participants enrollment target is mid-sized for trials with a published cap, below the 1,653-participant average among 52 other Medication Adherence trials with a reported enrollment target (89% lower).
The record links to 2 conditions, with Medication Adherence appearing as the primary indexed condition, and to 1 intervention - of which mHealth app/dashboard is the first listed.
NCT06023615 reports a single indexed study location in South Carolina.
Frequently Asked Questions
What is clinical trial NCT06023615 about?
NCT06023615 is a clinical study titled "MITIGAAT: Multifaceted Intervention to Improve Graft Outcome Disparities in African American Kidney Transplants". This is a randomized study to test a smartphone app that a pharmacist will use to help kidney transplant patients track their medications, blood pressures, and blood sugars in those with diabetes. The goal of this study is to improve care and outcomes in kidney transplant patients and, in particular...
What is the current status of trial NCT06023615?
This trial is currently recruiting. It is a NA study. The enrollment target is 190 participants. The study started on 2024-02-27. Estimated completion is 2027-10-31.
What conditions does trial NCT06023615 study?
This clinical trial studies the following conditions: Medication Adherence, Medication Compliance.
What interventions are being tested in trial NCT06023615?
The interventions under investigation include: mHealth app/dashboard (OTHER).
Who is sponsoring clinical trial NCT06023615?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06023615 being conducted?
This trial has 1 study location across South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Medication Adherence
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06023615's enrollment target sits among peer trials
190 21st of 52 higher than 32 of 52 other Medication Adherence trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Medication Adherence trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Mobile Gaming App to Improve Adherence to PrEP
RECRUITING · NA
-
1MoreStep: An Intervention to Increase HIV Care Engagement and Reduce Intimate Partner Violence Among Black Women Living With HIV
RECRUITING · NA
-
Medication Adherence Program
RECRUITING · NA
-
Improving Medication Adherence Using Family-focused and Literacy-sensitive Strategies
RECRUITING · NA
-
Refinement and Testing of Recruitment Methodology for Behavioral Medication Adherence Interventions Using Behavioral Science-based Approaches
RECRUITING · NA
-
Mobile Cued Adherence Therapy (mCAT) for Blood Pressure Medication
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03257033 · 190 participants · Phase 3
Intra-arterial Gemcitabine vs. IV Gemcitabine and Nab-Paclitaxel Following Radiotherapy for LAPC
- NCT03642028 · 190 participants · Phase 4
Suvorexant: A Dual Orexin Receptor Antagonist for Treating Sleep Disturbance in Posttraumatic Stress
- NCT04015609 · 190 participants · NA
Psychotherapy Intervention for Latinos With Advanced Cancer
- NCT04284397 · 190 participants · Early Phase 1
Identification of Critical Thermal Environments for Aged Adults
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI